VREX

NASDAQ Healthcare

Varex Imaging Corporation - Common Stock

Medical Devices

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

๐Ÿ“Š Market Data
Price$18.46
Volume1,059,457
Market Cap778.06M
Beta0.880
RSI (14-Day)94.1 Overbought
200-Day MA$11.86
50-Day MA$11.75
52-Week High$18.63
52-Week Low$9.09
P/E Ratio34.83
Forward P/E16.87
Price / Book1.64
๐ŸŽฏ Investment Strategy Scores

VREX scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 37/100โ–ผ -1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 12/100โ–ผ -1
High growth potential (high beta + oversold)
๐ŸŽˆ Over-Hyped 99/100โ€” 0
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐ŸŽˆ Over-Hyped (99/100) โ€” this strategy Overbought stocks (potential short candidates).

Lowest fit among scored strategies: ๐Ÿš€ Moon Shot (12/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find VREX in your text

Paste any article, transcript, or post โ€” the tool will extract VREX and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.